-
Vulvodynia Treatment Market 2027 – Status and Development, Average Product Price and Market Shares of Key Players
03 Nov 2022 07:53 GMT
Soaring cases of Vulvodynia is Projected to Drive Vulvodynia Treatment Market Growth
HYDERABAD, TELANGANA, INDIA, November 3, 2022 /EINPresswire.com/ -- Vulvodynia Treatment Market size is estimated to reach $77.4 billion by 2027, growing at a …
-
Mid-Day Market Update: Stocks Turn Higher; Depomed Shares Plummet
08 Aug 2017 16:45 GMT
… on Tuesday, basic materials shares were relative laggards, down … in idiopathic pulmonary fibrosis.
Shares of Cutera, Inc. (NASDAQ … its FY earnings forecast.
Shares of Depomed Inc (NASDAQ: DEPO) … guidance. Janney Capital downgraded Depomed from Buy to Neutral. …
-
Depomed shares down 13% after earnings miss
09 May 2017 20:41 GMT
Shares of Depomed Inc.
DEPO, +1.20%
fell … earnings and revenue below expectations. Depomed said it lost $27 million … . Adjusted for one-time items, Depomed earned $4 million, or 7 … sales of $100 million. Shares of Depomed ended the regular trading session …
-
Depomed Shares Down 30.2% Since SmarTrend's Sell Call (DEPO)
03 Mar 2017 05:39 GMT
…
SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October … MA has declined 0.2%.
DepoMed, Inc. develops new and … incorporated drug or drugs. DepoMed has also developed a system … in momentum for shares of Depomed.
Log in and add Depomed (DEPO) to …
-
Mid-Afternoon Market Update: Crude Oil Down Over 2%; Depomed Shares Spike Higher
07 Jan 2017 07:10 GMT
… to acquire remaining outstanding shares of Alon USA Energy, … to support enhanced coverage.
Shares of Depomed Inc (NASDAQ: DEPO) … agreed to acquire remaining outstanding shares of Alon USA.
Equities … Corp (NASDAQ: ITEK) shares dropped 73 percent to $ …
-
Gabapentin Market Significant Growth Prospects During 2019-2024 | Pfizer, Depomed, TEVA, Mylan, Arbor Pharma, Novartis, Apotex, Sun Pharmaceutical
24 Oct 2019 18:11 GMT
… covered in this report: Pfizer Depomed TEVA Mylan Arbor Pharma Novartis … presents a comprehensive overview, market shares, and growth opportunities of Gabapentin …
-
Assertio Therapeutics Inc (ASRT) Director, President and CEO Arthur J Higgins Bought $77,000 of Shares
13 Aug 2019 02:21 GMT
… (insider trades) bought 50,000 shares of ASRT on 08… this purchase was $77,000.
Depomed Inc is a specialty pharmaceutical … of $97.900 million; its shares were traded at around $1 … A. Peisert bought 19,000 shares of ASRT stock on 08 …
-
Depomed: 2Q Earnings Snapshot
08 Aug 2018 13:39 GMT
NEWARK, Calif. (AP) _ Depomed Inc. (DEPO) on Wednesday reported … expected $63.6 million.
Advertisement
Depomed shares have increased 16 percent since …
-
Depomed Announces Second-Quarter 2018 Financial Results
08 Aug 2018 11:30 GMT
… the live call.
About Depomed
Depomed is a leading specialty pharmaceutical … 63,611
62,331
Dilued shares used in calculation
63,719 … 28,030
$
12,577
Shares used in calculation (7)
82 … .86
)
Conversion from basic shares to diluted shares
0.07
…
-
Why Depomed Inc.'s Shares Soared 23.2% Higher
11 May 2018 13:06 GMT
… its full-year guidance, shares of Depomed Inc. (NASDAQ:DEPO) … fee. After four years, Depomed will receive double-digit … respectively, in Q1.
Additionally, Depomed improved its net loss guidance … Nucynta to Collegium provides Depomed with a predictable source …